acute hockey stick angle, the ETT can cause injury to the anterior part of the trachea. [2] There are many cases where either a broken stylet piece or torn sheath covering the stylet were found causing the airway obstruction. [3, 4] These may occur due to usage of an old brittle stylet or reusing the same stylet more than the recommended number of times.
With our technique, both stylet tip injuries and airway obstruction resulting from the broken brittle stylet can be taken care of as the tip of the stylet is well behind the Ryle's tube tip. Another advantage is that the same stylet can be reused making our approach highly cost-effective. However, we suggest to change the Ryles tube, covering stylet after each use and proper sterilisation of the stylet before mounting a new Ryle's tube. To reduce stylet-induced soft-tissue injuries, in addition to our technique, we also suggest avoiding excessive bending of stylet tip, use of adjustable rubber cock and proper jelly application before introducing the stylet into the ETT. [2, 5] We have been regularly using this technique in our institute. However, we suggest larger trials before this technique can be used widely.
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This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. Churg-Strauss syndrome (CSS) is a rare vasculitic disorder affecting multiple organs, characterised by asthma, hypereosinophilia and necrotising vasculitis. [1] Patients are generally aged 20-40 years with no gender predominance. Scarce information is available in the volume in 1 s 77%, forced expiratory ratio 76%). Transthoracic echocardiogram revealed normal left ventricular size and systolic function. There was mild eosinophilia (2.3 × 10 9 /L), but other blood tests were normal. Since diagnosis, she had been on fluctuating doses of prednisolone, titrated to her flares and ceased when asthma symptoms resolved. On admission, she was on stable daily prednisolone 5 mg, mycophenolate 1 g, and regularly inhaled bronchodilator. After pre-medication with intravenous glycopyrrolate 0.2 mg, magnesium 8 mmol and midazolam 3 mg, anaesthesia was induced with propofol 130 mg, ketamine 20 mg, fentanyl 100 µg, rocuronium 50 mg and lignocaine 80 mg, followed by endotracheal intubation. Hydrocortisone 25 mg was administered after induction. Retrospectively, this could have been omitted as latest evidence suggests she had a low risk of hypothalamic-pituitary-adrenal-axis suppression and did not require perioperative stress-dose steroid. [2] Anaesthesia was maintained with sevofluorane. During surgery, further rocuronium bolus was given to target train-of-four count of '0' using a nerve stimulator for adequate paralysis. Fentanyl 100 µg/h, ketamine 20 mg/h and lignocaine 80 mg/h were infused for analgesia throughout the case (total: fentanyl 300 mcg, ketamine 60 mg and lignocaine 240 mg). Ropivacaine 200 mg was injected into the abdominal walls at the conclusion of surgery. Sugammadex 2 mg/kg (200 mg) was given followed by confirmation of neuromuscular blockade reversal using a nerve stimulator and successful extubation. Postoperatively, regular paracetamol, fentanyl-based patient-controlled analgesia and ketamine infusion of 0.1-0.2 mg/kg/h were commenced for analgesia.
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Given the risk of CSS on airway hyperreactivity, anaesthetists should be prepared to prevent and manage a bronchoconstrictive response. We recognise that neuraxial techniques such as spinal or combined spinal and epidural are favourable alternatives, but undertook GA given her disease stability. We gave glycopyrrolate pre-induction to minimise airway secretions. Ketamine and magnesium are both bronchodilatory and analgesic through their actions on the N-methyl-D-aspartate receptors. Intravenous lignocaine attenuates reflex bronchoconstriction and decreases post-operative pain, ileus, hospital stay and nausea and vomiting. [3] We used 1 mg/kg bolus followed by 1 mg/kg/h infusion during the intraoperative period. Sevofluorane has bronchodilatory effects, minimises histamine-induced bronchospasm and decreases airway responsiveness.
We used fentanyl and rocuronium, avoiding histamine-releasing drugs such as morphine and atracurium. Few case reports described caution or complete avoidance of non-depolarising muscle relaxant to avoid using neostigmine and physostigmine as reversals which can cause bradycardia, increased secretions and bronchial hyperreactivity. [4, 5] This strategy may not always be practical as in our case, which required deep paralysis for optimal operating conditions. We used sugammadex to overcome these problems associated with the standard reversal agents. This is advantageous for adequate paralysis throughout the case and subsequent rapid reversal.
Taylor et al. reported decreased plasma cholinesterase activity in two patients with CSS following suspected abnormal sensitivity to suxamethonium. [6] Without information regarding patient's plasma cholinesterase level or activity, caution should be exercised when using suxamethonium or mivacurium as their metabolism relies on this enzyme. Therefore, if a patient requires a rapid sequence induction, but abnormal sensitivity to suxamethonium is to be avoided, rocuronium can be considered the paralytic agent of choice, and sugammadex can be successfully used for reversal of neuromuscular blockade.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given her consent for her clinical information to be reported in the journal. The patient understands that name and initials will not be published and due efforts will be made to conceal identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Nil.
